Today, seven entities meet the basic criteria to compete for a contract to supply the National Institute on Drug Abuse with research-grade cannabis, and it could be worth up to $25 million.
The request for information is NIH’s first on these barriers, and it includes eight participants, from the National Cancer Institute to the National Institute on Aging.
For decades, it’s been the University of Mississippi. This time around, new growers in the U.S. are eligible.
The research comes amid a broader agency effort to collect data on cannabinoids, which will help shape forthcoming rules on approved products.
This is the first-ever NCI grant dedicated to “studies that address patterns of tobacco and cannabis use as a target for cancer prevention and control.”
An agency within the U.S. Department of Health and Human Services released its first annual update of an ongoing systematic review of cannabis and pain.
In September, a widely-covered study found that youth use declined after the passage of medical and adult use cannabis laws. But methodological issues have led to a retraction.
For decades, there was one DEA-approved entity. Now there are five, though the DEA has been quiet about it. But what about the dozens of other applicants?
CSU Pueblo hosted National Institute on Drug Abuse division director Susan Weiss, who discussed NIDA’s research priorities and future work.
In an investigation published in JAMA, researchers concluded that the rise “highlights the need for immediate policy change and implementation.”
The study, published in JAMA Pediatrics, shows that teen vaping has spiked in the U.S. and Canada.
The National Institute for Occupational Safety and Health analyzed state cannabis laws and rules on workers compensation and cannabis.
A study finds that consumption rises among white people, but not among Black people–even as Black people face more legal jeopardy. The study found no increase in youth use.
More workers base their recommendations on customer experience with cannabis products than on clinician input, a new JAMA study found.
Federal agencies want to support research on cannabis and the effects of THC, and various products from vape cartridges to edibles, using a newly-established standard dose of THC.
The latest Monitoring the Future study data, released Wednesday by NIH’s National Institute on Drug Abuse, also found that hallucinogen consumption is up while alcohol consumption is down.